Next Article in Journal
Role of PA2G4P4 pseudogene in bladder cancer tumorigenesis
Previous Article in Journal
Phylogenetic Analyses of Sites in Different Protein Structural Environments Result in Distinct Placements of the Metazoan Root
 
 
Review
Peer-Review Record

Osteoarthritis and Toll-Like Receptors: When Innate Immunity Meets Chondrocyte Apoptosis

by Goncalo Barreto 1,2,*, Mikko Manninen 3 and Kari K. Eklund 1,2,3
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Submission received: 24 February 2020 / Revised: 26 March 2020 / Accepted: 28 March 2020 / Published: 30 March 2020

Round 1

Reviewer 1 Report

In this review article, the authors provide an overview of the TLR-induced innate immune responses during osteoarthritis development setting the focus on articular chondrocyte apoptosis.

In general, the topic is relevant and interesting, however, there are some points that need improvement and clarification.

  1. The authors state in the abstract that “Apoptosis is of particular importance, given that chondrocyte death is a dominant feature in OA“ and the title „1. Introduction: The Role of Inflammation and Apoptosis in OA“ announces that information on chondrocyte apotosis will be provided in this section. This information is missing. The authors should provide a passage on the importance of chondrocyte apoptosis in OA pathogenesis (difference to necrosis regarding TLR-mediated effects ….?).
  2. Line 41: „resident tissues“ should be resident cells and „matrices“ matrix
  3. Section 2, lines 52-70: Please, provide references for passage 1, 2 and 3.
  4. Section 2, line 59: be careful with wording. „The enzymatic degradation of articular cartilage IS the erosion of pericellular matrix and eventually the interterritorial matrix“
  5. Section 2, line 71: First, the authors describe that cartilage degradation is prominent in the superficial zone and pericellular matrix (which is present in all zones….). Then, in the next sentence, they wrote that at this zone and throughout the osteoarthritic cartilage MMPs etc are associated with matrix degradation. This is confusing. What happens where?
  6. Section 2, lines 79-85: in my opinion, this general information should come earlier, especially because healthy situation is described. As next, OA situation with disturbed anabolic-catabolic balance could follow…
  7. Fig.1: Please define the abbreviations CPII, C2C, NO, PIIANP in the legende.
  8. Fig. 2: does apoptosis (induced by NFkB, left) mean the same as type 1 IFN-induced cell death (right)?
  9. Fig.2: Please define HMBG1, FBN, BGN, CpG-DNA etc. in the legende.
  10. Line 202: reference error
  11. Table1: I miss the reference to Table 1 in the manuscript text.
  12. Section 4: TLR and Chondrocyte Apoptosis would be more clear

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 2 Report

Biology-741529

Comments to the authors

This review by Barreto, G., et al., is an interesting and necessary review on osteoarthritis and TLRs, with particular emphasis on the role of TLR signaling in chondrocyte apoptosis.  However, the authors should also mention 2 recent reviews about the same topic or quite similar:

  • Danger signals and inflammaging in osteoarthritis by Millerand, M., et al. Exp. Rheumatol. 2019; 37 (Suppl. 120): S48-S56.
  • Inflammation in osteoarthritis: is it time to dampen the alarm(in) in this debilitating disease? Exp. Immunol., 2018; 195: 153–166.

There are some editing errors along the manuscript that should carefully revised by the authors. Thus, in line 202, the phrase “Error! Reference source not found.1” has no sense at all. My guess is that should be changed by “Table 1” instead.

In line 232, the b of “TGF-b-activated kinase 1” should be substituted by the Greek symbol β, or spelled out as “TGF-beta-activated kinase 1”

In line 328, the same for the a in “IL-1a”, it should be IL-1α

Author Response

Please see the attachment

Author Response File: Author Response.docx

Round 2

Reviewer 1 Report

The authors did respond to all of my questions suggestions.

Back to TopTop